SG10201602507UA - Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor - Google Patents

Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor

Info

Publication number
SG10201602507UA
SG10201602507UA SG10201602507UA SG10201602507UA SG10201602507UA SG 10201602507U A SG10201602507U A SG 10201602507UA SG 10201602507U A SG10201602507U A SG 10201602507UA SG 10201602507U A SG10201602507U A SG 10201602507UA SG 10201602507U A SG10201602507U A SG 10201602507UA
Authority
SG
Singapore
Prior art keywords
medium
cell culture
protein expression
culture medium
pam inhibitor
Prior art date
Application number
SG10201602507UA
Inventor
Corinna Sonderegger
Julia Schmutzhard
Christine Heel
Thomas Stangler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SG10201602507UA publication Critical patent/SG10201602507UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0031Serum-free culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/005Protein-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/71Oxidoreductases (EC 1.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201602507UA 2010-11-09 2011-11-09 Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor SG10201602507UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10190532A EP2450375A1 (en) 2010-11-09 2010-11-09 Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor

Publications (1)

Publication Number Publication Date
SG10201602507UA true SG10201602507UA (en) 2016-05-30

Family

ID=43795181

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2013034871A SG190182A1 (en) 2010-11-09 2011-11-09 Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
SG10201602507UA SG10201602507UA (en) 2010-11-09 2011-11-09 Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2013034871A SG190182A1 (en) 2010-11-09 2011-11-09 Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor

Country Status (13)

Country Link
US (2) US9062337B2 (en)
EP (2) EP2450375A1 (en)
JP (2) JP6298295B2 (en)
KR (2) KR101905204B1 (en)
CN (2) CN103298830A (en)
AU (1) AU2011328166B2 (en)
CA (1) CA2816394A1 (en)
DK (1) DK2638064T3 (en)
HU (1) HUE055573T2 (en)
PL (1) PL2638064T3 (en)
SG (2) SG190182A1 (en)
SI (1) SI2638064T1 (en)
WO (1) WO2012062810A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090074040A (en) 2006-09-13 2009-07-03 아보트 러보러터리즈 Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
SG10201702951RA (en) 2008-10-20 2017-06-29 Abbvie Inc Viral inactivation during purification of antibodies
SG10201702922VA (en) 2008-10-20 2017-06-29 Abbvie Inc Isolation and purification of antibodies using protein a affinity chromatography
EP2450375A1 (en) 2010-11-09 2012-05-09 Sandoz Gmbh Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
KR20170124618A (en) * 2012-04-16 2017-11-10 레크 파마슈티칼스 디.디. Reduction of formation of amidated amino acids in cell lines for protein expression
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
JP2016527911A (en) 2013-08-20 2016-09-15 レック・ファーマシューティカルズ・ディー・ディーLek Pharmaceuticals D.D. Cell culture media and process for controlling α-amidation and / or C-terminal amino acid cleavage of polypeptides
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CN109843904A (en) 2016-10-17 2019-06-04 恩泽生物科学有限公司 For reducing the heterogeneous continuation method of human cytokines
US20220177818A1 (en) 2019-04-01 2022-06-09 The Automation Partnership (Cambridge ) Ltd. Operation process for a cell cultivation system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1482031B1 (en) * 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
JP2008529495A (en) * 2005-02-04 2008-08-07 グラクソ グループ リミテッド Optimization of heterologous polypeptide expression
US20080227134A9 (en) * 2005-09-16 2008-09-18 Unigene Laboratories Inc. Glyoxylate assays and their use of inden tifying natural amidated compounds
JP5088136B2 (en) * 2005-10-18 2012-12-05 味の素株式会社 Method for producing succinic acid
FR2962656A1 (en) 2010-07-15 2012-01-20 Oleg Iliich Epshtein METHOD FOR INCREASING THE EFFECT OF AN ACTIVATED-POTENTIALIZED FORM OF ANTIBODY
EP2450375A1 (en) 2010-11-09 2012-05-09 Sandoz Gmbh Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor

Also Published As

Publication number Publication date
WO2012062810A3 (en) 2012-07-05
US9062337B2 (en) 2015-06-23
KR101905204B1 (en) 2018-10-05
KR20130131355A (en) 2013-12-03
JP2017035084A (en) 2017-02-16
EP2450375A1 (en) 2012-05-09
KR20180082643A (en) 2018-07-18
EP2638064B1 (en) 2021-07-21
AU2011328166A1 (en) 2013-05-30
JP2013541963A (en) 2013-11-21
WO2012062810A2 (en) 2012-05-18
DK2638064T3 (en) 2021-10-04
JP6298295B2 (en) 2018-03-20
US20150267238A1 (en) 2015-09-24
PL2638064T3 (en) 2021-12-20
AU2011328166B2 (en) 2017-02-23
US20130337506A1 (en) 2013-12-19
CN103298830A (en) 2013-09-11
CA2816394A1 (en) 2012-05-18
KR101991215B1 (en) 2019-09-30
US10106828B2 (en) 2018-10-23
EP2638064A2 (en) 2013-09-18
SI2638064T1 (en) 2021-11-30
SG190182A1 (en) 2013-06-28
CN107629995A (en) 2018-01-26
HUE055573T2 (en) 2021-12-28

Similar Documents

Publication Publication Date Title
SG10201602507UA (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
IL273159A (en) Culture medium composition, and method for culturing cell or tissue using said composition
PL2393917T3 (en) Culture medium for epithelial stem cells and organoids comprising said stem cells.
IL226971B (en) Cell culture medium
EP2582788A4 (en) Serum-free chemically defined cell culture medium
HK1171790A1 (en) Cell culture medium for adamts protein expression adamts
EP2561065A4 (en) Cell culture medium comprising small peptides
EP2644694A4 (en) Method and culture medium for improving pluripotent stem cell differentiation inducing efficiency
GB2497059B (en) Culture medium, method for culturing listeria,and method for dtecting listeria
EP2554657A4 (en) Method for separating cells, cell culture medium, and device for separating cells
GB2460552B (en) Stem cell culture media and methods
EP2843041A4 (en) Stem cell culture medium and method for culturing stem cells using same
EP2491111A4 (en) Cell culture/handling product and method for production and use thereof
HK1147218A1 (en) Stem cell lines, their application and culture methods
GB201113641D0 (en) Cell culture support and cell culture method
EP2480655B8 (en) Cell culture medium
HUE050984T2 (en) Culture medium for epithelial stem cells and organoids comprising said stem cells
AU2010901922A0 (en) Media and methods for cell culture
AU2009901852A0 (en) Media and methods for cell culture
PT3061808T (en) Culture medium for epithelial stem cells and organoids comprising said stem cells
GB0821363D0 (en) Stem cell culture media and methods
GB0810304D0 (en) Stem cell culture media and methods
GB201007863D0 (en) Bioreactor for cell culture